CFTR and cystic fibrosis: NBS programs that screen for all CF-causing variants in CFTR2, but do not implement a CFTR sequencing tier, may consider referring only infants with two CF-causing CFTR variants for sweat testing and diagnostic follow-up if this achieves 95% sensitivity and aligns with program goals.